Fatigue rating scales: an empirical comparison

Taylor, Renée R.; Jason, Leonard A.; Torres, Ana

doi:10.1017/s0033291799002500

Cited by 97 publications

(69 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, fatigue was observed at baseline, as indicated by a fatigue severity scale score of .36 [35], and a nonsignificant fall was observed after 3 months of ASV therapy, bringing this score back into the normal range. Fatigue has not been evaluated in comparable intervention trials.…”

Section: Discussionmentioning

confidence: 95%

Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial

et al. 2012

View full text Add to dashboard Cite

We tested the hypotheses that in patients with congestive heart failure (CHF) and sleep disordered breathing (SDB) auto-servoventilation (ASV) improves cardiac function and quality of life.Between March 2007 and September 2009, patients with stable CHF (left ventricular ejection fraction (LVEF) f40%) and SDB (apnoea/hypopnoea index o20 events?h -1 ) were randomised to receive either ASV (BiPAP ASV (Philips Respironics, Murrysville, PA, USA), n537) and optimal medical management, or optimal medical management alone (n535). Outcomes were assessed at baseline and 12 weeks.The apnoea/hypopnoea index assessed with polysomnography scored in one core laboratory was significantly more reduced in the ASV group (-39¡16 versus -1¡13 events?h . Both groups showed similar improvements of the primary end-point LVEF (+3.4¡5 versus +3.5¡6%; p50.915) assessed with echocardiography. In the ASV group, reduction of N-terminal probrain natriuretic peptide (NT-proBNP) was significantly greater (-360¡569 versus +135¡625 ng?mL -1 ; p50.010). No differences were observed between the groups in subjective quality of life.In patients with CHF and SDB, ASV reduced NT-proBNP levels, but improvement of LVEF or quality of life was not greater than in the control group. The data support that such patients can be randomised in large-scale, long-term trials of positive airway pressure therapy versus control to determine effects on cardiovascular outcome. @ERSpublications Patients with heart failure and sleep apnoea can be randomised in long-term trials of positive airway pressure therapy http://ow.ly/nQnVg

show abstract

Section: Discussionmentioning

confidence: 95%

Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial

et al. 2012

View full text Add to dashboard Cite

show abstract

“…Although the expected association was not defined, a head-to-head comparison of the ChalderFS (index and domain scores) and FSS following completion by a large patient group (n = 166) reported very low correlations between the two measures, suggesting that they measure different aspects of fatigue [100]. The FSS had stronger correlations with variables reflecting CFS severity and the generic Short-Form 36-item Health Survey (SF-36) [101], leading the authors to suggest that the FSS provides a more comprehensive reflection of fatigue-related severity, symptomology and functional disability than the ChFS.…”

Section: Measurement Propertiesmentioning

confidence: 91%

Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review

2011

View full text Add to dashboard Cite

The quality and acceptability of reviewed PROMs is limited, and recommendations for patient-reported assessment are difficult. Significant methodological and quality issues in PROM development/evaluation were identified by the appraisal framework, which must be addressed in future research. Clear discrepancies exist between what is measured in research and how patients define their experience of CFS/ME. Future PROM development/evaluation must seek to involve patients more collaboratively to measure outcomes of importance using relevant and credible methods of assessment.

show abstract

“…In addition, the Fatigue Severity Scale (Krupp et al, 1989) was normed on a sample of individuals with MS, SLE, and healthy controls. A study by Taylor, Jason and Torres (2000) found that, within a CFS-like group, the Fatigue Severity Scale was associated with severity ratings for the eight Fukuda et al (1994) CFS symptoms. (Friedberg, 1996), a quantitative measure of depression severity was used.…”

Section: Methodsmentioning

confidence: 99%

The Associations Between Basal Salivary Cortisol and Illness Symptomatology in Chronic Fatigue Syndrome

Torres-Harding

Sorenson

Jason

et al. 2008

J Appl Biobehavioral Res

View full text Add to dashboard Cite

Hypocortisolism has been reported in chronic fatigue syndrome (CFS), with the significance of this finding to disease etiology unclear. This study examined cortisol levels and their relationships with symptoms in a group of 108 individuals with CFS. CFS symptoms examined included fatigue, pain, sleep difficulties, neurocognitive functioning, and psychiatric status. Alterations in cortisol levels were examined by calculation of mean daily cortisol, while temporal variation in cortisol function was examined by means of a regression slope. Additionally, deviation from expected cortisol diurnal pattern was determined via clinical judgment. Results indicated that fatigue and pain were associated with salivary cortisol levels. In particular, variance from the expected pattern of cortisol was associated with increased levels of fatigue. The implications of these findings are discussed.Keywords salivary cortisol; chronic fatigue syndrome; cognitive functioning; pain; fatigue Chronic fatigue syndrome (CFS) is an illness characterized by severe, disabling fatigue that is not alleviated with rest, and by flu-type symptoms including sore throats, muscle pain, joint pain, headaches, memory/concentration difficulties, unrefreshing sleep, and postexertional malaise (Fukuda, et al. 1994). The causes of CFS are currently unknown, and, as of yet, no clear diagnostic marker for this illness has emerged. Physiological studies have suggested the presence of dysfunction in the immune, endocrine, and neurological systems, NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript and researchers have found numerous abnormalities in these systems. However, many of these physiological abnormalities have not been replicated across studies, and a confusing picture still exists regarding the pathophysiology of this illness. Most recently, it has been suggested that individuals with CFS constitute a heterogeneous population, and little progress in clearly delineating the physiology of this illness may have resulted because of the presence of distinct subgroups within this larger umbrella diagnosis (Jason, Corradi, Torres-Harding, Taylor, & King, 2005).However, some abnormalities have been more consistently reported in the literature as affecting a subset of individuals with CFS. One finding frequently reported is a dysfunction of the hypothalamic-pituitary-adrenal axis, (HPA) with resulting hypocortisolism (Addington, 2000;Cleare, 2003). Cortisol, a glucocorticoid, is the major end product of the HPA axis and is involved in regulation of several bodily systems. Some researchers have noted that approximately 20-25% of individuals with CFS and related disorders such as fibromyalgia or post-traumatic stress disorder have exhibited hypocortisolism and downregulation of the HPA axis (Fries, Hesse, Hellhammer, & Hellhammer, 2005). Cleare (2003), in a review of the literature examining HPA dysfunction in CFS, found that many, but not all, studies of cortisol in CFS found lower levels of baseline cortisol and changes in sen...

show abstract

Fatigue rating scales: an empirical comparison

Cited by 97 publications

References 12 publications

Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial

Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial

Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review

The Associations Between Basal Salivary Cortisol and Illness Symptomatology in Chronic Fatigue Syndrome

Contact Info

Product

Resources

About